• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社区居住老年人的药品购买情况:比较生命最后两年的人和多活至少两年的人。

Purchases of medicines among community-dwelling older people: comparing people in the last 2 years of life and those who lived at least 2 years longer.

作者信息

Pulkki Jutta, Aaltonen Mari, Raitanen Jani, Rissanen Pekka, Jylhä Marja, Forma Leena

机构信息

Faculty of Social Sciences, Tampere University, Tampere, Finland.

出版信息

Eur J Ageing. 2019 Nov 14;17(3):361-369. doi: 10.1007/s10433-019-00543-9. eCollection 2020 Sep.

DOI:10.1007/s10433-019-00543-9
PMID:32904873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7459050/
Abstract

While it is known that those who are living their last years are frequent users of social and health services, research about medicines at the end of life is scarce. We examined whether the proportions of purchasers and the types of prescription medicines purchased during a 2-year period differed between community-dwelling old people who died (decedents) in 2002, 2006 or 2011 and old people who lived at least 2 years longer (survivors) in Finland. We also examined how those differences changed over time. The study population was identified from nationwide registers and consisted of 174,097 community-dwelling people who were 70 years of age or older. Of these, 81,893 were decedents and 92,204 survivors. Data on purchases of medicines were gathered from the Finnish prescription database. Along with descriptive analyses, binary logistic regression analysis was used to find the association between decedent status and the purchase of medicines in general and different categories of medicines in particular. Almost all community-dwelling decedents and survivors purchased medicines at least once during the 2-year period. Over time, the proportion of purchasers increased in both groups but especially among survivors, thereby reducing the differences between the groups. However, the probability of purchasing medicines in general and different categories of medicine in particular remained significantly higher for decedents than for survivors after adjustments. This study shows that purchases of medication are concentrated at the end of life, as is the use of social and health services. However, the differences between decedents and survivors diminish over time.

摘要

虽然已知那些处于生命最后几年的人经常使用社会和医疗服务,但关于临终时用药的研究却很匮乏。我们研究了在芬兰,2002年、2006年或2011年去世的(已故)社区居住老年人与至少多活了2年的(存活者)老年人在2年期间购买者的比例以及所购买处方药的类型是否存在差异。我们还研究了这些差异如何随时间变化。研究人群从全国登记册中确定,由174,097名70岁及以上的社区居住者组成。其中,81,893人为已故者,92,204人为存活者。药品购买数据从芬兰处方药数据库收集。除了描述性分析外,还使用二元逻辑回归分析来找出已故状态与一般药品购买以及特定类别药品购买之间的关联。几乎所有社区居住的已故者和存活者在2年期间至少购买过一次药品。随着时间的推移,两组中购买者的比例都有所增加,但存活者中增加得尤为明显,从而缩小了两组之间的差异。然而,经过调整后,已故者购买一般药品和特定类别药品的可能性仍然显著高于存活者。这项研究表明,药物购买集中在生命末期,社会和医疗服务的使用也是如此。然而,已故者和存活者之间的差异会随着时间的推移而减小。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d882/7459050/28b5531a10f2/10433_2019_543_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d882/7459050/28b5531a10f2/10433_2019_543_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d882/7459050/28b5531a10f2/10433_2019_543_Fig1_HTML.jpg

相似文献

1
Purchases of medicines among community-dwelling older people: comparing people in the last 2 years of life and those who lived at least 2 years longer.社区居住老年人的药品购买情况:比较生命最后两年的人和多活至少两年的人。
Eur J Ageing. 2019 Nov 14;17(3):361-369. doi: 10.1007/s10433-019-00543-9. eCollection 2020 Sep.
2
Care service use in 2 years preceding suicide among older adults: comparison with those who died a natural death and those who lived longer.老年人自杀前两年的护理服务使用情况:与自然死亡者及长寿者的比较。
Eur J Ageing. 2016 Oct 4;14(2):143-153. doi: 10.1007/s10433-016-0397-9. eCollection 2017 Jun.
3
Long-term care is increasingly concentrated in the last years of life: a change from 2000 to 2011.长期护理越来越集中在生命的最后几年:这是 2000 年至 2011 年的变化。
Eur J Public Health. 2017 Aug 1;27(4):665-669. doi: 10.1093/eurpub/ckw260.
4
Medicine use in people with intellectual disabilities: a Finnish nationwide register study.智力残疾者的药物使用情况:一项芬兰全国登记研究。
J Intellect Disabil Res. 2023 Dec;67(12):1291-1305. doi: 10.1111/jir.12988. Epub 2022 Nov 13.
5
A comparison by payor/provider type of the cost of dying among frail older adults.按付款人/提供者类型对体弱老年人临终成本进行的比较。
J Am Geriatr Soc. 1996 Sep;44(9):1098-107. doi: 10.1111/j.1532-5415.1996.tb02947.x.
6
Risk Factors for Long-term Mortality and Patterns of End-of-Life Care Among Medicare Sepsis Survivors Discharged to Home Health Care.医疗保险脓毒症幸存者出院后居家医疗的长期死亡率风险因素和临终关怀模式。
JAMA Netw Open. 2020 Feb 5;3(2):e200038. doi: 10.1001/jamanetworkopen.2020.0038.
7
Trends in inpatient treatment intensity among Medicare beneficiaries at the end of life.临终时医疗保险受益人的住院治疗强度趋势。
Health Serv Res. 2004 Apr;39(2):363-75. doi: 10.1111/j.1475-6773.2004.00232.x.
8
The 'third class' of medications: Sales and purchasing behavior are associated with pharmacist only and pharmacy medicine classifications in Australia.第三类药物:在澳大利亚,销售和购买行为仅与药剂师及药房药品分类相关。
J Am Pharm Assoc (2003). 2009 Jan-Feb;49(1):31-7. doi: 10.1331/JAPhA.2009.07117.
9
The importance of proximity to death in modelling community medication expenditures for older people: evidence from New Zealand.在为老年人构建社区药物支出模型时临近死亡的重要性:来自新西兰的证据。
Appl Health Econ Health Policy. 2014 Dec;12(6):623-33. doi: 10.1007/s40258-014-0121-x.
10
Changes in the use of cardiovascular medicines in the elderly aged 75 years or older--a population-based Kuopio 75+ study.75岁及以上老年人心血管药物使用情况的变化——一项基于人群的库奥皮奥75+研究。
J Clin Pharm Ther. 2007 Jun;32(3):253-9. doi: 10.1111/j.1365-2710.2007.00819.x.

引用本文的文献

1
Community purchases of antimicrobials during the COVID-19 pandemic in Uganda: An increased risk for antimicrobial resistance.乌干达新冠疫情期间社区对抗菌药物的购买情况:抗菌药物耐药性风险增加
PLOS Glob Public Health. 2023 Feb 23;3(2):e0001579. doi: 10.1371/journal.pgph.0001579. eCollection 2023.
2
Health system reforms and the needs of the ageing population-an analysis of recent policy paths and reform trends in Finland and Sweden.卫生系统改革与老龄化人口的需求——芬兰和瑞典近期政策路径与改革趋势分析
Eur J Ageing. 2022 Apr 15;19(2):221-232. doi: 10.1007/s10433-022-00699-x. eCollection 2022 Jun.

本文引用的文献

1
Discontinuation of medications at the end of life: A population study in Belgium, based on linked administrative databases.生命末期停止用药:基于关联行政数据库的比利时人群研究。
Br J Clin Pharmacol. 2019 Apr;85(4):827-837. doi: 10.1111/bcp.13874. Epub 2019 Feb 22.
2
Barriers and enablers to deprescribing in people with a life-limiting disease: A systematic review.限制和促进生命末期患者药物减量的因素:系统评价。
Palliat Med. 2019 Jan;33(1):37-48. doi: 10.1177/0269216318801124. Epub 2018 Sep 19.
3
Drug consumption and futile medication prescribing in the last year of life: an observational study.
生命终末期的药物消耗和无效药物处方:一项观察性研究。
Age Ageing. 2018 Sep 1;47(5):749-753. doi: 10.1093/ageing/afy054.
4
Health and social service use among old people in the last 2 years of life.老年人生命最后两年的健康与社会服务利用情况。
Eur J Ageing. 2007 Aug 8;4(3):145-154. doi: 10.1007/s10433-007-0054-4. eCollection 2007 Sep.
5
Choosing Wisely? Measuring the Burden of Medications in Older Adults near the End of Life: Nationwide, Longitudinal Cohort Study.明智选择?衡量临终老年人的药物负担:全国纵向队列研究。
Am J Med. 2017 Aug;130(8):927-936.e9. doi: 10.1016/j.amjmed.2017.02.028. Epub 2017 Apr 25.
6
Defining polypharmacy in the elderly: a systematic review protocol.老年人多重用药的定义:一项系统评价方案。
BMJ Open. 2016 Mar 24;6(3):e010989. doi: 10.1136/bmjopen-2015-010989.
7
The Burden of Polypharmacy in Patients Near the End of Life.临终患者多重用药的负担
J Pain Symptom Manage. 2016 Feb;51(2):178-83.e2. doi: 10.1016/j.jpainsymman.2015.09.003. Epub 2015 Sep 30.
8
Use of hospital and long-term institutional care services in relation to proximity to death among older people in Finland.与芬兰老年人接近死亡相关的医院和长期机构护理服务的使用。
Soc Sci Med. 2013 Jul;88:39-47. doi: 10.1016/j.socscimed.2013.03.042. Epub 2013 Apr 10.
9
Comparison of prescription drug use between community-dwelling and institutionalized elderly in Sweden.瑞典社区居住和机构居住老年人处方药使用的比较。
Drugs Aging. 2012 Sep;29(9):751-8. doi: 10.1007/s40266-012-0002-7.
10
Drug therapy optimization at the end of life.生命终末期的药物治疗优化。
Drugs Aging. 2012 Jun 1;29(6):511-21. doi: 10.2165/11631740-000000000-00000.